Takatsugu Ogata
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
A multicenter Phase II study of mFOLFOX6 plus nivolumab for gastric cancer with severe peritoneal metastases: WJOG16322G.
Journal: Future oncology (London, England)
Published: June 06, 2025
Clinical and prognostic characteristics of metastatic colorectal cancer with minor RAS mutations.
Journal: Oncology letters
Published: March 17, 2025
Investigation of the association between therapeutic effectiveness of anamorelin and Glasgow prognostic score in patients with cancer cachexia: a competing risk analysis.
Journal: Investigational new drugs
Published: November 11, 2024
Optimal Primary Prophylaxis for Febrile Neutropenia During Neoadjuvant Cisplatin and 5-Fluorouracil Plus Docetaxel for Esophageal Cancer: A Retrospective Cohort Study.
Journal: Cancer medicine
Published: July 05, 2024
Chronological improvement of survival in patients with advanced gastric cancer over 15 years.
Journal: Therapeutic advances in medical oncology
Published: September 10, 2023
Differential Efficacy of Targeted Monoclonal Antibodies in Left-Sided Colon and Rectal Metastatic Cancers.
Journal: Clinical colorectal cancer
Published: March 05, 2023
First experience of a fully decentralized clinical trial: The dawn of a new era in oncology.
Journal: Cancer science
Published: January 13, 2023
Nivolumab versus irinotecan as third- or later-line treatment for advanced gastric cancer: a multi-center retrospective study.
Journal: International journal of clinical oncology
Published: December 04, 2022
Last Updated: 09/26/2026